CD47 and neoplasm: P-selectin and CD47 on PLTM enable PLTMNPs to target subcutaneous and metastatic tumors, escape phagocytosis by Mø, effectively inhibit tumor invasion and metastasis, and avoid causing hematotoxicity [114].